Joshua Rotenberg, MD
Specialty Board Certifications:
Neurology – Special Qualifications in Child Neurology, Sleep Medicine, Pediatrics
Special Qualifications in Child Neurology & Additional Qualifications in Sleep Medicine for Adults & Children, Pediatrics
American Academy of Neurology, Child Neurology Society, American Academy of Sleep Medicine, American Epilepsy Society, American Headache Society, American Academy of Cerebral Palsy & Developmental Medicine
Epilepsy, Cerebral Palsy, Concussion/Brain Injury, Headache, Developmental disorders
Directorships & Academic Appointments:
Courtesy Staff Texas Children’s Hospital, Assistant Clinical Professor Pediatric Neurology UT Houston
Houston, San Antonio, Seguin
Brown University, Honors AB
Brown University School of Medicine MD
Brown University, Masters in Medical Science
Internal Medicine, Lenox Hill Hospital, New York University
Pediatrics, Wright Patterson AFB/Dayton Children’s Hospital, Wright State University
Child & Adolescent Neurology, National Capital Consortium – WRAMC, NNMC, NIH, USUHS
Hobbies and Outside Interests:
Photography, Dogs, Travel
Marital Status and Number of Children:
Married, 4 Children
Sub Investigator: JPI protocol 07-001: A Phase 2a, Open-label, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects with Epileptic Seizures. 2008-Present
Sub Investigator: GlaxoSmithKline TRX106573: A Study of Combination Product (sumatriptan succinate and naproxen sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Eletriptan. 2006
Sub Investigator: Torrey Pines NGX424MIG2001: A Double-Blind, ,Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Safety, Efficacy and Tolerance of a Single Subcutaneous Dose of Tezampanel in Patients with Acute Migraine. 2007
Sub Investigator: PRA International NO1280/NO1281: A Multi-Center Double-Blind, Historical Control Randomized Conversion to Monotherapy with Keppra XR for Treatment of Partial Onset Seizure Study. 2007-Present
Publications – Peer Reviewed
Shoemaker M, Richards K, Rotenberg J. Safety and Tolerability of Levetiracetam in Neonates. Journal of Child Neurology. Accepted for Publication
Rotenberg JS, Canard K, DiFazio M. Successful Treatment of Refractory Restless Legs Syndrome with Botulinum Toxin Injections. Journal of Clinical Sleep Medicine. Volume 2(3).
Joseph K, Richards K, Rotenberg JS. Rash, Fever, and Neck Pain in the Office: Is this a Neurologic Emergency. Pediatric Ann. 2005 NOV.
Schmid C, Rotenberg JS. Neurodevelopmental Toxicology. Neurol Clin. 2005 May; 23(2): 321-36.
Rotenberg JS, Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics. 2003 Sep; 112(3 Pt 1): 648-58.
Rotenberg J, Pearl PL. Landau-Kleffner syndrome. Archives of Neurology 2003 Jul; 60(7): 1019-21.
Rotenberg J. Nerve Agents in Children. Annals of Pediatrics. Pediatric Ann. 2003 Apr; 32(4): 242-50.
Rotenberg J. Cyanide as a Weapon of Terror. Annals of Pediatrics. Pediatric Ann. 2003 Apr;32(4):236-40.
Rotenberg JS, Burklow TR, Selanikio JS Weapons of mass destruction: the decontamination of children. Pediatric Ann. 2003 Apr; 32(4): 260-7.
Grunspan A., Rotenberg J. Options for treating insomnia vary in type and effectiveness. San Antonio Business Journal. October 13, 2008.
Rotenberg J. Sleep Disorders in Women. NSide MD San Antonio. October 17, 2007.
Rotenberg J. Worker fatigue takes its toll. San Antonio Business Journal. Friday, July 27, 2007
Rotenberg J. Nerve Agents In Children: Dosing Card. http://ccc.apgea.army.mil/reference_materials/reference.asp; 2002.
Rotenberg J. Nerve Agents In Children: Guidelines. http://ccc.apgea.army.mil/reference_materials/reference.asp; 2002.
Brackett E, Rotenberg J and Sherman C. “A Case of Hantavirus Infection in New England” letter to the editor, New England Journal of medicine, 3313(8), August 25, 1994.
Rotenberg J “Adapting the Clinical Encounter for the Deaf Patient”, Rhode Island Medicine, 77, March 1994, p.76-78.
Rotenberg J. “Black-Jewish Relations in Colonial Newport” Rhode Island Jewish Historical Notes, 11(2), November 1992, p.117-172.
Kiel M, Rotenberg J. Inadequate Screening for Sleep Disorders in Children with Down Syndrome. APSS, Salt lake city UT, 2006.
Shoemaker M, Rotenberg J, Richards K. Safety and Tolerability of Levetiracetam in Infants. Poster Presentation, American Epilepsy Society, Washington DC 2005.
Rotenberg JS. Successful Treatment of Refractory Restless Legs Syndrome with Botulinum Toxin Injections – A Case Series. Poster Presentation APSS, Denver CO, 2005.
Kudelko K, Rotenberg J, DiFazio M. Successful Treatment of Restless Legs Syndrome with Local Injections of Botulinum Toxin A. Poster presented at the Movements Disorders Society Annual meeting, Miami, FL November 2002.
Barnes K, Rotenberg J, DiFazio M. “Flaccid Monoplegia in Neonate after Lumbar Puncture” Poster presented at 36th Annual Uniformed Services Pediatric Seminar, 2002.